These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 33151938)
1. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model. Ndung'u K; Murilla GA; Thuita JK; Ngae GN; Auma JE; Gitonga PK; Thungu DK; Kurgat RK; Chemuliti JK; Mdachi RE PLoS One; 2020; 15(11):e0229060. PubMed ID: 33151938 [TBL] [Abstract][Full Text] [Related]
2. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients. Kagira JM; Maina N Onderstepoort J Vet Res; 2007 Mar; 74(1):17-22. PubMed ID: 17708149 [TBL] [Abstract][Full Text] [Related]
3. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania. Kibona SN; Matemba L; Kaboya JS; Lubega GW Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338 [TBL] [Abstract][Full Text] [Related]
4. Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei. Dukes P Trans R Soc Trop Med Hyg; 1984; 78(6):711-25. PubMed ID: 6241967 [TBL] [Abstract][Full Text] [Related]
5. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Nok AJ Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807 [TBL] [Abstract][Full Text] [Related]
6. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense. Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376 [TBL] [Abstract][Full Text] [Related]
7. Response of a T. b. rhodesiense stock with reduced drug susceptibility in vitro to treatment in mice and cattle. Enyaru JC; Matovu E; Lubega GW; Kaminsky R Acta Trop; 1998 Jun; 69(3):261-9. PubMed ID: 9638278 [TBL] [Abstract][Full Text] [Related]
8. A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats. Anene BM; Ezeokonkwo RC; Mmesirionye TI; Tettey JN; Brock JM; Barrett MP; De Koning HP Parasitology; 2006 Jan; 132(Pt 1):127-33. PubMed ID: 16393361 [TBL] [Abstract][Full Text] [Related]
9. Physiological and proteomic profiles of Trypanosoma brucei rhodesiense parasite isolated from suramin responsive and non-responsive HAT patients in Busoga, Uganda. Mutuku CN; Bateta R; Rono MK; Njunge JM; Awuoche EO; Ndung'u K; Mang'era CM; Akoth MO; Adung'a VO; Ondigo BN; Mireji PO Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():57-67. PubMed ID: 33588295 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis. Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303 [TBL] [Abstract][Full Text] [Related]
11. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985]. Pérez Martín O; Lastre González M; Urban M; Shwalbach J Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188 [TBL] [Abstract][Full Text] [Related]
12. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. Graf FE; Ludin P; Wenzler T; Kaiser M; Brun R; Pyana PP; Büscher P; de Koning HP; Horn D; Mäser P PLoS Negl Trop Dis; 2013; 7(10):e2475. PubMed ID: 24130910 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Ugandan Trypanosoma brucei rhodesiense isolated from man and animal reservoirs to diminazene, isometamidium and melarsoprol. Matovu E; Iten M; Enyaru JC; Schmid C; Lubega GW; Brun R; Kaminsky R Trop Med Int Health; 1997 Jan; 2(1):13-8. PubMed ID: 9018298 [TBL] [Abstract][Full Text] [Related]
14. Flow cytofluorimetric analysis of drug accumulation by multidrug-resistant Trypanosoma brucei brucei and T. b. rhodesiense. Frommel TO; Balber AE Mol Biochem Parasitol; 1987 Nov; 26(1-2):183-91. PubMed ID: 3431564 [TBL] [Abstract][Full Text] [Related]
15. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance. Bernhard SC; Nerima B; Mäser P; Brun R Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691 [TBL] [Abstract][Full Text] [Related]
16. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO). Iten M; Matovu E; Brun R; Kaminsky R Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023 [TBL] [Abstract][Full Text] [Related]
17. Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense. Graf FE; Ludin P; Arquint C; Schmidt RS; Schaub N; Kunz Renggli C; Munday JC; Krezdorn J; Baker N; Horn D; Balmer O; Caccone A; de Koning HP; Mäser P Cell Mol Life Sci; 2016 Sep; 73(17):3387-400. PubMed ID: 26973180 [TBL] [Abstract][Full Text] [Related]
18. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda. Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206 [TBL] [Abstract][Full Text] [Related]
19. The pathogenicity of diminazene aceturate-resistant Trypanosoma brucei in rats after treatment with the drug. Egbe-Nwiyi TN; Igbokwe IO; Onyeyili PA J Comp Pathol; 2003; 128(2-3):188-91. PubMed ID: 12634097 [TBL] [Abstract][Full Text] [Related]
20. Diminazene aceturate resistance on the virulence of Trypanosoma brucei for rats. Egbe-Nwiyi TN; Igbokwe IO; Onyeyili PA J Comp Pathol; 2005 Nov; 133(4):286-8. PubMed ID: 16271938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]